Pfizer Partners With Tempus to Advance Oncology Drug Development
Pfizer will have access to Tempus' artificial intelligence-powered platform, data library, companion diagnostics platform, and clinical trial matching program.
Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk.
The short oligo ligation assembly (SOLA) enzymatic DNA synthesis method uses a library of DNA building blocks to make oligos that are then assembled into genes.
The purchase of GeneDx from Opko Health will help Sema4 accelerate its push into whole-exome sequencing and grow in rare disease diagnostics.